Palisade Bio

Palisade Bio Palisade Bio (Nasdaq: PALI) is advancing next-generation oral PDE4 inhibitor prodrugs for inflammatory and fibrotic diseases.

06/11/2026

“We are pleased to welcome both Robert and Jordan to the Palisade Bio Board of Directors,” said JD Finley, Chief Executive Officer of Palisade Bio. Palisade's Board is strengthened by the addition of Mr. Baltera's and Mr. Zwick's extensive biotechnology leadership, strategic transactions and capital markets expertise. Read more: https://bit.ly/4vCbCvd

06/11/2026

Palisade Bio today announced the addition of industry veterans Robert Baltera and Jordan Zwick to its Board of Directors. Learn more: https://bit.ly/4vCbCvd

06/10/2026

Mitchell Jones, MD, PhD, President and Chief Medical Officer of Palisade Bio discussed the significant unmet need associated with FSCD, the biological mechanisms underlying intestinal fibrosis, and the potential role of locally bioactivated PDE4 inhibition as a novel therapeutic approach. Learn more about the presentation at the New York Academy of Sciences (“NYAS”) symposium, Molecular Pathways and Cellular Players in the Resolution of Organ Fibrosis: https://bit.ly/4xeBzmp

06/09/2026

"Fibrosis remains one of the most significant challenges facing patients with Crohn's disease, yet there are currently no approved therapies specifically designed to address FSCD," said Mitchell Jones, MD, PhD, President and Chief Medical Officer of Palisade Bio. Read more: https://bit.ly/4xeBzmp

06/09/2026

Palisade today announced Mitchell Jones, MD, PhD, President and Chief Medical Officer, will present at the New York Academy of Sciences symposium, Molecular Pathways and Cellular Players in the Resolution of Organ Fibrosis, taking place on June 9, 2026, in New York, NY. For details: https://bit.ly/4xeBzmp

06/04/2026

Tune-in today, June 4th at 3:45 PM ET for a presentation from JD Finley, Chief Executive Officer, and Dr. Mitchell Jones, President and Chief Medical Officer of Palisade Bio, at the Jefferies Global Healthcare Conference: https://bit.ly/4fKMjSY

06/01/2026

On Thursday, June 4th at 3:45 PM ET, JD Finley, CEO, and Dr. Mitchell Jones, President and Chief Medical Officer of Palisade Bio, will present at the Jefferies Global Healthcare Conference.

Register for the webcast here: https://bit.ly/4fKMjSY

05/27/2026

JD Finley, Chief Executive Officer, and Dr. Mitchell Jones, President & Chief Medical Officer of Palisade Bio, will present at the Jefferies Global Healthcare Conference on Thursday, June 4th at 3:45 PM ET.

For details: https://bit.ly/4u2wnzg

05/19/2026

Today is , a global movement to stand with the millions of people living with Ulcerative Colitis and Crohn's disease worldwide.

Ulcerative Colitis and Crohn's disease are chronic conditions where many patients face relapsing inflammation, loss of treatment response, and in some cases irreversible bowel damage, despite approved existing therapies.

That's the gap we're working to close.

Palisade's lead program, PALI-2108, is a once-daily oral PDE4 inhibitor prodrug designed to be selectively bioactivated in the ileum and colon, initiating targeted PDE4 inhibition at sites of disease while enabling systemic distribution of the active drug. PALI-2108 is being developed for the potential treatment of Ulcerative Colitis and Crohn's disease.

Learn about our pipeline: https://bit.ly/3P9Ou84

05/13/2026

“We continue to see a consistent and differentiated profile emerging for PALI-2108 across IBD,” said JD Finley, Chief Executive Officer of Palisade Bio. Palisade plans to advance into Phase 2 development of PALI-2108 in both ulcerative colitis and Crohn’s disease. For recent highlights and anticipated milestones, visit: https://bit.ly/4u1XhrC

Address

5800 Armada Drive, Suite 210
Carlsbad, CA
92008

Telephone

+18587044900

Website

Alerts

Be the first to know and let us send you an email when Palisade Bio posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Palisade Bio:

Shortcuts

Share

Category